Latest kidney cancer news
![](https://actionkidneycancer.org/wp-content/uploads/2024/03/hands-4811698_1280-1024x643.jpg)
25 Mar 2024
How to manage anxiety and depression when you have kidney cancer
![](https://actionkidneycancer.org/wp-content/uploads/2023/11/artificial-intelligence-3382507_1280-1024x682.jpg)
12 Mar 2024
Immunotherapy improves survival in kidney cancer patients with brain metastases
![](https://actionkidneycancer.org/wp-content/uploads/2021/02/Kidney-cancer-2.jpg)
8 Mar 2024
Radiotherapy for the management of renal medullary carcinoma
![](https://actionkidneycancer.org/wp-content/uploads/2024/03/Manchester-focus-group.jpeg)
8 Mar 2024
Manchester patient focus group
![](https://actionkidneycancer.org/wp-content/uploads/2021/02/NICE-1.jpg)
8 Mar 2024
NICE approves cabozantinib plus nivolumab for advanced kidney cancer
![](https://actionkidneycancer.org/wp-content/uploads/2021/02/Kidney-Cancer-1-1-1024x436.jpg)
15 Feb 2024
PRISM study highlights possibility of reducing dose of immunotherapy
![](https://actionkidneycancer.org/wp-content/uploads/2021/02/Radiotherapy-2.jpg)
15 Feb 2024
World-class radiotherapy in the UK
![](https://actionkidneycancer.org/wp-content/uploads/2021/07/asco_logo-1024x546.jpeg)
7 Feb 2024
Summary of kidney cancer highlights from ASCO GU 2024
![](https://actionkidneycancer.org/wp-content/uploads/2021/02/Cancer-cells-3d-Rendering-1024x1024.jpg)
2 Feb 2024
Cancer treatment could identify patients most likely to respond to cancer drugs
![](https://actionkidneycancer.org/wp-content/uploads/2021/07/asco_logo-1024x546.jpeg)
2 Feb 2024
Belzutifan and shows better quality of life compared to everolimus
![](https://actionkidneycancer.org/wp-content/uploads/2021/02/Kidney-cancer-treatment.jpg)
18 Jan 2024
Lenvatinib plus pembrolizumab for advanced kidney cancer
![](https://actionkidneycancer.org/wp-content/uploads/2021/07/Kidney-Cancer-1-1024x436.jpeg)
16 Jan 2024